Iron infusion for children and teens with iron deficiency anemia
Treatments studied
Part of Blood & lymphatic, Hormones & metabolism clinical trials.
This trial tests an iron infusion called ferric carboxymaltose to treat iron deficiency anemia in children and teens seen in the emergency department. It aims to improve their hemoglobin levels and overall health.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 1 and 18 years old.
- Your hemoglobin must be between 6.0 and 10.0 g/dL.
- You must be stable (not in critical condition).
- You cannot have active bleeding (other than menstrual bleeding), recent injury causing blood loss, cancer, low platelets, or an active infection.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies whether taking iron by mouth can improve iron levels and anemia (low red blood cell counts) in children with chronic kidney disease. It may help reduce fatigue and support normal blood-making, by comparing different approaches for children who meet specific iron test results.
This trial studies IV ferric derisomaltose to treat iron deficiency anemia in children under 18. It is meant for children whose anemia is from a true iron problem and who either cannot tolerate or do not respond to iron taken by mouth, or have certain kidney-related causes.
This trial tests ferumoxytol, an intravenous iron medicine, to treat iron deficiency anemia in children who cannot take or did not respond well to iron by mouth. It aims to improve blood iron levels and anemia symptoms safely.
This study compares two intravenous iron treatments to see if one works as well as the other in people with iron deficiency anemia. It may help improve your iron levels and reduce anemia symptoms.
This trial tests whether giving intravenous iron to adults hospitalized with heart failure and low iron levels helps improve their health. You may be eligible if you have heart failure with reduced pumping function and low iron stores.
This trial tests whether giving an intravenous iron supplement (ferric derisomaltose) can help prevent anemia and improve quality of life in obese patients who have low iron stores. It aims to see if this treatment can boost energy and reduce fatigue.
Hear when a new Iron Deficiency Anemia Treatment trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.